MENU
+Compare
RMD
Stock ticker: NYSE
AS OF
Apr 25, 04:59 PM (EDT)
Price
$235.85
Change
-$0.25 (-0.11%)
Capitalization
29.13B

RMD ResMed Forecast, Technical & Fundamental Analysis

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more

RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RMD with price predictions
Apr 24, 2025

Momentum Indicator for RMD turns positive, indicating new upward trend

RMD saw its Momentum Indicator move above the 0 level on April 21, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RMD just turned positive on April 14, 2025. Looking at past instances where RMD's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

RMD moved above its 50-day moving average on April 24, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RMD advanced for three days, in of 350 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for RMD moved below the 200-day moving average on April 08, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RMD broke above its upper Bollinger Band on April 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RMD entered a downward trend on April 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.215) is normal, around the industry mean (23.728). P/E Ratio (31.344) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (1.839) is also within normal values, averaging (5.667). Dividend Yield (0.010) settles around the average of (0.018) among similar stocks. P/S Ratio (6.203) is also within normal values, averaging (41.794).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RMD is expected to report earnings to rise 3.38% to $2.45 per share on July 31

ResMed RMD Stock Earnings Reports
Q2'25
Est.
$2.45
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.11
Q3'24
Beat
by $0.15
Q2'24
Est.
$2.08
The last earnings report on April 23 showed earnings per share of $2.37, missing the estimate of $2.39. With 268.52K shares outstanding, the current market capitalization sits at 29.13B.
A.I.Advisor
published Dividends

RMD paid dividends on March 20, 2025

ResMed RMD Stock Dividends
А dividend of $0.53 per share was paid with a record date of March 20, 2025, and an ex-dividend date of February 13, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of devices for evaluation and treatment of sleep disorders

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9001 Spectrum Center Boulevard
Phone
+1 858 836-5000
Employees
10140
Web
https://www.resmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JAGX8.061.39
+20.84%
Jaguar Health Inc
HSII38.540.78
+2.07%
Heidrick & Struggles International
BAP196.053.50
+1.82%
Credicorp Ltd
UBFO8.760.09
+1.04%
United Security Bancshares
AVA41.26-0.25
-0.60%
Avista Corp

RMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with IDXX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then IDXX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+10.10%
IDXX - RMD
37%
Loosely correlated
+3.36%
RVTY - RMD
35%
Loosely correlated
+1.55%
OM - RMD
33%
Loosely correlated
-3.47%
NVST - RMD
32%
Poorly correlated
+1.65%
INSP - RMD
32%
Poorly correlated
+6.63%
More